Login
Definium Therapeutics, Inc. logo

Definium Therapeutics, Inc.

definiumtx.com

The filing excerpts provided do not contain sufficient business description content to produce a SEC-grounded company summary for Definium Therapeutics Inc (DFTX). The excerpts include only the table of contents and header information from the 10-K filed 2026-02-26 (accession 000119312526076742), without substantive text from Item 1 Business, financial statements, or any other sections that would support factual claims about the company's business model, revenue streams, products, customers, competitors, or geographic footprint. A canonical description cannot be written without misrepresenting unsupported facts.

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$353.8M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
694.7%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
918.7M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $5.118 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support